Pulmonary Disease Doctors in Warwick, RI Accepting Medicare

5 Pulmonary Disease doctors found. Showing 1 - 5

Anuradha Ramaswamy, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 455 Toll Gate Rd, Warwick, RI 02886 Phone: 401-273-0641

Joseph Paul Padayhag, M.D. Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 215 Toll Gate Rd, Suite 301, Warwick, RI 02886 Phone: 401-738-5500

Dr. Stephen Lawrence Matarese, DO Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 215 Toll Gate Rd, Suite 301, Warwick, RI 02886 Phone: 401-732-1508    Fax: 401-732-1592

Dr. Thomas Joseph Raimondo, Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1050 Warwick Ave, Warwick, RI 02888 Phone: 401-467-6257    Fax: 401-785-1191

Dr. Robert Edward Baute, M.D. Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 455 Toll Gate Rd, Wound Recovery And Hyperbaric Medicine Center, Warwick, RI 02886 Phone: 401-736-4646    Fax: 401-736-4248

News Archive

New procedure to estimate reproductive potential of individual embryos

To address the high rate of multiple births resulting from in-vitro-fertilization (IVF), researchers at Yale School of Medicine and McGill University have developed a procedure that estimates the reproductive potential of individual embryos, possibly leading to a decrease in multiple-infant births and a higher success rate in women undergoing IVF.

A child's risk of becoming obese may begin before birth and continue throughout infancy

A child's risk of becoming obese may begin before birth and continue throughout infancy and early childhood - critical periods for cellular growth and development, according to research results discussed during a national conference and outlined in the October supplement to Pediatrics.

New opioid medication may slow the progression of osteoarthritis

A novel preclinical study by Keck Medicine of USC researchers, published in Arthritis & Rheumatology, reveals that a potential new opioid medication may have the ability to slow the progression of osteoarthritis while being less addictive than commonly prescribed opioid drugs.

Roche announces results of phase III taspoglutide study in diabetes patients

Ipsen, an innovation-driven global specialty pharmaceutical group, today announced that its partner Roche has disclosed the results of the second and third of eight T-emerge phase III studies in patients with diabetes for taspoglutide, the first human once weekly glucagon-like peptide-1 (GLP-1) analogue originating from Ipsen's research and developed by Roche.

FDA requires sleep drugs that contain zolpidem to lower recommended doses

The U.S. Food and Drug Administration today announced it is requiring the manufacturers of Ambien, Ambien CR, Edluar and Zolpimist, widely used sleep drugs that contain the active ingredient zolpidem, to lower current recommended doses. Ambien and Ambien CR are also available as generics.

Read more Medical News

› Verified 3 days ago